SEC Form 4 · accession 0001553878-15-000031
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Akshay Vaishnaw
Officer — EVP, R&D, CMO
Period of report
Nov 25, 2015
Accepted (ET)
Nov 30, 2015 · 5:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 25, 2015 | M | 835 | $22.75 | A | 835 | D | |
| Common Stock | Nov 25, 2015 | M | 4,915 | $16.43 | A | 5,750 | D | |
| Common StockF1 | holding | — | — | — | 132 | I | By Managed Account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $16.43 | Nov 25, 2015 | M | 4,915 | D | — | Dec 9, 2019 | Common Stock | 4,915 | 40,085 | D |
| Stock Option (Right to Buy)F2 | $22.75 | Nov 25, 2015 | M | 835 | D | — | Dec 13, 2016 | Common Stock | 835 | 29,165 | D |
Explanation of responses
- F1The reporting person owns 132 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- F2The stock option vests as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares each successive three month period thereafter.